Status: Recruiting
The Safety and Efficacy of GMDTC for Injection in Subjects With Elevated Cadmium Levels
This is a randomized, double-blind, placebo-controlled, single-center Phase IIa clinical study.
Participants needed: 11
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Guangdong Jianersheng Pharmaceutical Technology Co., Ltd.Updated: Sep 2, 2025Locations: 1
Eligibility criteria
Voluntarily sign the informed consent form, aged between 18 and 70 years (inclus... [+2]
Currently suffering from any clinically significant disease that, in the investi... [+4]